Alkermes
ALKS
41.45
-0.21
-0.49%
Alkermes
US · ALKS
#1780 by market cap
Listed 1970
41.45
-0.21
-0.49%
Live - 5344 symbols - heartbeat 105s ago
· 2026-10-08 07:21
Pre-market
40.96
-1.17%
After-hours
41.45
0.00%
- Market cap
- 6.95B
- P/E (TTM)i
- 109.07
- P/Bi
- 3.84
- EPSi
- 1.43
- Div yieldi
- 0.00%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on ALKS?
Anonymous reader poll. Unscientific, not investment advice.
About Alkermes
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
- Founded
- 2011
- CEO
- Mr. Blair C. Jackson
- Employees
- 2,050
- Headquarters
- Dublin, Dublin, Ireland
- Fiscal year end
- 12-31
- Website
- alkermes.com
Company profile
- Exchange
- US
- Symbol
- ALKS
- Market-cap rank
- #1780
- Listing date
- 1970-01-01
- Market cap
- 6.95B
- Float cap
- 6.43B
- Shares out
- 167.76M
- Float shares
- 155.20M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-10-08 07:21:04 · For reference only, not investment advice and not tailored to your situation.